Detalles de la búsqueda
1.
[CUTANEOUS METASTASIS OF UROTHERIAL CARCINOMA FOR WHICH MOHS PASTE WAS USEFUL: A CASE REPORT].
Nihon Hinyokika Gakkai Zasshi
; 108(1): 41-44, 2017.
Artículo
en Japonés
| MEDLINE | ID: mdl-29367508
2.
Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma.
Curr Urol
; 17(1): 52-57, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37692134
3.
Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents.
Int Urol Nephrol
; 54(6): 1225-1232, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314918
4.
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor.
Urol Oncol
; 40(10): 455.e11-455.e18, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35851184
5.
Erratum: Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.
Mol Clin Oncol
; 15(2): 155, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34178326
6.
Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor.
Curr Urol
; 15(4): 187-192, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35069080
7.
Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.
Mol Clin Oncol
; 12(6): 557-564, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32337038
8.
Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.
Can Urol Assoc J
; 14(11): E582-E587, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32520703
9.
The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
Urol Oncol
; 35(11): 662.e1-662.e7, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28778585
Resultados
1 -
9
de 9
1
Próxima >
>>